FORM OF COMMON STOCK PURCHASE WARRANT MED-X, INC.Med-X, Inc. • February 9th, 2024 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20281 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Med-X, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elec
●] UNITS EACH UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK MED-X, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2024 • Med-X, Inc. • Pharmaceutical preparations • New York
The undersigned, MED-X, INC., a company incorporated under the laws of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which MAXIM GROUP LLC (“Maxim”) is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
WARRANT AGENCY AGREEMENTWarrant Agency Agreement • February 9th, 2024 • Med-X, Inc. • Pharmaceutical preparations
WARRANT AGENCY AGREEMENT (this “Warrant Agreement”) dated as of [____], 2023 (the “Issuance Date”) between Med-X, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC (the “Warrant Agent”).
AMENDMENT NO. 1 TO AGREEMENT FOR THE PURCHASE AND SALE OF CAPITAL STOCKMed-X, Inc. • February 9th, 2024 • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO THE AGREEMENT FOR THE PURCHASE AND SALE OF CAPITAL STOCK (“Agreement”) by and between MED-X, INC. (“Purchaser”) and JOSEPH WINOGRADE (“Seller”) shall be deemed effective as of December 13, 2023.
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • February 9th, 2024 • Med-X, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE (“Agreement”), shall be deemed effective as of December 13, 2023, by and between MED-X, INC. (the “Company”) and JOSEPH WINOGRADE (the “Holder”).
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • February 9th, 2024 • Med-X, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE (“Agreement”), shall be deemed effective as of December 13, 2023, by and between MED-X, INC. (the “Company”) and JOSEPH WINOGRADE (the “Holder”).
AMENDMENT NO. 1 TO AGREEMENT FOR THE PURCHASE AND SALE OF CAPITAL STOCKMed-X, Inc. • February 9th, 2024 • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO THE AGREEMENT FOR THE PURCHASE AND SALE OF CAPITAL STOCK (“Agreement”) by and between MED-X, INC. (“Purchaser”) and JOSEPH WINOGRADE (“Seller”) shall be deemed effective as of December 13, 2023.
